Striatal parvalbuminergic neurons are lost in Huntington's disease: Implications for dystonia

Movement Disorders

Volumn 28, Issue 12, 2013, Pages 1691-1699

  Reiner, Anton ^a   Shelby, Evan ^a   Wang, Hongbing ^a   Demarch, Zena ^a   Deng, Yunping ^a   Guley, Natalie Hart ^a   Hogg, Virginia ^b   Roxburgh, Richard ^b,c   Tippett, Lynette J ^b   Waldvogel, Henry J ^b   Faull, Richard L M ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Dystonia; Huntington's disease; Parvalbuminergic interneurons; Striatum

Indexed keywords

NEUROPEPTIDE Y; SOMATOSTATIN;

ADULT; ANTIBODY LABELING; ARTICLE; CASE REPORT; CORPUS STRIATUM; DYSTONIA; FEMALE; GLOBUS PALLIDUS; HUMAN; HUNTINGTON CHOREA; INTERNEURON; MALE; MOTOR DYSFUNCTION; NERVE CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUTAMEN;

DYSTONIA; HUNTINGTON'S DISEASE; PARVALBUMINERGIC INTERNEURONS; STRIATUM;

ADULT; AGED; AGED, 80 AND OVER; CORPUS STRIATUM; DYSTONIA; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NERVE DEGENERATION; NEURONS; PARVALBUMINS;

EID: 84886442235     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25624     Document Type: Article

References (74)

1. Albin RL, Tagle DA. Genetics and molecular biology of HD. Trends Neurosci 1995;18:11-14.
2. Guo Z, Rudow G, Pletnikova O, et al. Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease. Mov Disord 2012;27:1379-1386.
3. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
4. Albin RL, Reiner A, Anderson KD, Penney JB, Young AB. Striatal and nigral neuron subpopulations in rigid HD: implications for the functional anatomy of chorea and rigidity-akinesia. Ann Neurol 1990;27:357-365.
5. Deng YP, Albin RL, Penney JB, Young AB, Anderson KD, Reiner A. Differential loss of striatal projection systems in HD: a quantitative immunohistochemical study. J Chem Neuroanat 2004;27:143-164.
6. Reiner A, Albin RL, Anderson KD, D'Amato CJ Penney JB, Young AB. Differential loss of striatal projection neurons in HD. Proc Natl Acad Sci U S A 1988;85:5733-5737.
7. Sapp E, Ge P, Aizawa H, et al. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade HD using high resolution image analysis. Neuroscience 1995;64:397-404.
8. Feigin A, Kieburtz K, Bordwell K, et al. Functional decline in HD. Mov Disord 1995;10:211-214.
9. Kirkwood SC, Su JL, Conneally PM, Foroud T. Progression of symptoms in the early and middle stages of HD. Arch Neurol 2001;58:273-278.
10. Louis ED, Lee P, Quinn L, Marder K. Dystonia in HD: prevalence and clinical characteristics. Mov Disord 1999;14:95-101.
11. DeLong M. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285.
12. Kravitz AV, Freeze BS, Parker PR, et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 2010;466:622-626.
13. Deng YP, Shelby E, Reiner A. Immunohistochemical localization of AMPA type glutamate receptor subunits in the striatum of Rhesus monkey. Brain Res 2010;1344:104-123.
14. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC. Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci 1995;18:527-535.
15. Kita H. GABAergic circuits of the striatum. Prog Brain Res 1993;99:51-72.
16. Koos T, Tepper JM. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat Neurosci 1999;2:467-472.
17. Lapper SR, Smith Y, Sadikot AF, Parent A, Bolam JP. Cortical input to parvalbumin-immunoreactive neurons in the putamen of squirrel monkey. Brain Res 1992;580:215-224.
18. Rudkin TM, Sadikot AF. Thalamic input to parvalbumin-immunoreactive GABAergic interneurons: organization in normal striatum and effect of neonatal decortication. Neuroscience 1999;88:1165-1175.
19. Tepper JM, Koos T, Wilson CJ. GABAergic microcircuits in the neostriatum. Trends Neurosci 2004;27:662-669.
20. sz mutants. J Neurosci 2001;21:RC153.
21. Gernert M, Richter A, Löscher W. Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters. Brain Res 1999;821:277-285.
22. Gernert M, Richter A, Löscher W. Subconvulsive dose of pentylenetetrazole increases the firing rate of substantia nigra pars reticulata neurons in dystonic but not in nondystonic hamsters. Synapse 1999;33:259-267.
23. Gernert M, Richter A, Löscher W. In vivo extracellular electrophysiology of pallidal neurons in dystonic and nondystonic hamsters. J Neurosci Res 1999;57:894-905.
24. Gernert M, Hamann M, Bennay M, Löscher W, Richter A. Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia. J Neurosci 2000;20:7052-7058.
25. Gernert M, Bennay M, Fedrowitz M, Rehders JH, Richter A. Altered discharge pattern of basal ganglia output neurons in an animal model of idiopathic dystonia. J Neurosci 2002;22:7244-7253.
26. Gittis AH, Leventhal DK, Fensterheim BA, Pettibone JR, Berke JD, Kreitzer AC. Selective inhibition of striatal fast-spiking interneurons causes dyskinesias. J Neurosci 2011;31:15727-15731.
27. Dom R, Baro F, Brucher JM. A cytometric study of the putamen in different types of Huntington's chorea. In: Barbeau A, Chase TN, Paulson GW, eds. Huntington's Chorea. Advances in Neurology. Vol. 1. New York: Raven Press; 1973:369-385.
28. Ferrer I, Kulisevsky J, Gonzalez G, Escartin A, Chivite A, Casas R. Parvalbumin-immunoreactive neurons in the cerebral cortex and striatum in HD. Neurodegeneration 1994;3:169-173.
29. Harrington KM, Kowall NW. Parvalbumin immunoreactive neurons resist degeneration in HD striatum. J Neuropathol Exp Neurol 1991;50:309.
30. Ferrante RJ, Kowall NW, Beal MF, Martin JB, Bird ED, Richardson EP Jr. Morphological and histochemical characteristics of a spared subset of striatal neurons in HD. J Neuropathol Exp Neurol 1987;46:12-27.
31. Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 1997;41:689-692.
32. Waldvogel HJ, Curtis MA, Baer K, Rees MI, Faull RLM. Immunohistochemical staining of post-mortem adult human brain sections. Nat Protoc 2006;1:2719-2732.
33. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP. Neuropathological classification of HD. J Neuropathol Exp Neurol 1985;44:559-577.
34. Celio MR. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 1990;35:375-475.
35. Figueredo-Cardenas G, Harris CL, Anderson KD, Reiner A. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types. Exp Neurol 1998;149:356-372.
36. Meade CA, Figueredo-Cardenas G, Fusco FR, Nowak TS, Pulsinelli W, Reiner A. Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease. Exp Neurol 2000;166:307-323.
37. Thu DC, Oorschot DE, Tippett LJ, et al. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain 2010;133:1094-1110.
38. Richter A, Löscher W. Pathophysiology of idiopathic dystonia: findings from genetic animal models. Prog Neurobiol 1998;54:633-677.
39. Kreil A, Hamann M, Sander SE, Richter A. Changes in dynorphin immunoreactivity but unaltered density of enkephalin immunoreactive neurons in basal ganglia nuclei of genetically dystonic hamsters. Synapse 2011;65:1196-1203.
40. Muramatsu S, Yoshida M, Nakamura S. Electrophysiological study of dyskinesia produced by microinjection of picrotoxin into the striatum of the rat. Neurosci Res 1990;7:369-380.
41. Yoshida M, Nagatsuka Y, Muramatsu S, Niijima K. Differential roles of the caudate nucleus and putamen in motor behavior of the cat as investigated by local injection of GABA antagonists. Neurosci Res 1991;10:34-51.
42. Breedveld GJ, Dongen JWF, Danesino C, et al. Mutations in TITF-1 are associated with benign hereditary chorea. Hum Mol Genet 2002;11:971-979.
43. Hashimoto T. Neuronal activity in the globus pallidus in primary dystonia and off-period dystonia. J Neurol 2000;247(Suppl 5):V49-V52.
44. Hutchison WD, Lang AE, Dostrovsky JO, Lozano AM. Pallidal neuronal activity: implications for models of dystonia. Ann Neurol 2003;53:480-488.
45. Sanghera MK, Grossman RG, Kalhorn CG, Hamilton WJ, Ondo WG, Jankovic J. Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy. Neurosurgery 2003;52:1358-1373.
46. Vitek JL, Chockkan V, Zhang JY, et al. Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann Neurol 1999;46:22-35.
47. Zhuang P, Li Y, Hallett M. Neuronal activity in the basal ganglia and thalamus in patients with dystonia. Clin Neurophysiol 2004;115:2542-2557.
48. Mallet N, Le Moine C, Charpier S, Gonon F. Feedforward inhibition of projection neurons by fast-spiking GABA interneurons in the rat striatum in vivo. J Neurosci 2005;25:3857-3869.
49. Gittis AH, Nelson AB, Thwin MT, Palop JJ, Kreitzer AC. Distinct roles of GABAergic interneurons in the regulation of striatal output pathways. J Neurosci 2010;30:2223-2234.
50. Planert H, Szydlowski SN, Hjorth JJ, Grillner S, Silberberg G. Dynamics of synaptic transmission between fast-spiking interneurons and striatal projection neurons of the direct and indirect pathways. J Neurosci 2010;30:3499-3507.
51. Lei WL, Jiao Y, Del Mar N, Reiner A. Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. J Neurosci 2004;24:8289-8299.
52. Reiner A, Hart NM, Lei W, Deng Y. Corticostriatal projection neurons-dichotomous types and dichotomous functions. Front Neuroanat 2010;4:142.
53. Ramanathan S, Hanley JJ, Deniau JM, Bolam JP. Synaptic convergence of motor and somatosensory cortical afferents onto GABAergic interneurons in the rat striatum. J Neurosci 2002;22:8158-8169.
54. Wilson CJ. The contribution of cortical neurons to the firing pattern of striatal spiny neurons. In: Houk JC, Davis JL, Beiser DG, eds. Models of Information Processing in the Basal Ganglia. Cambridge, MA: MIT Press; 1995:29-50.
55. Gage GJ, Stoetzner CR, Wiltschko AB, Berke JD. Selective activation of striatal fast-spiking interneurons during choice execution. Neuron 2010;67:466-479.
56. Berke JD. Uncoordinated firing rate changes of striatal fast-spiking interneurons during behavioral task performance. J Neurosci 2008;28:10075-10080.
57. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex, Ann Rev Neurosci 1986;9:357-381.
58. Wymbs NF, Bassett DS, Mucha PJ, Porter MA, Grafton ST. Differential rcruitment of the sensorimotor putamen and frontoparietal cortex during motor chunking in humans. Neuron 2012;74:936-946.
59. Ferrante RJ, Beal MF, Kowall NW, Richardson EP, Martin JB Jr. Sparing of acetylcholinesterase-containing striatal neurons in HD. Brain Res 1987;411:162-166.
60. Gonzales C, Lin RC, Chesselet MF. Relative sparing of GABAergic interneurons in the striatum of gerbils with ischemia-induced lesions. Neurosci Lett 1992;135:53-58.
61. Mallard EC, Waldvogel HJ, Williams CE, Faull RL, Gluckman PD. Repeated asphyxia causes loss of striatal projection neurons in the fetal sheep brain. Neuroscience 1995;65:827-836.
62. Agerman K, Ernfors P. Differential influence of BDNF and NT3 on the expression of calcium binding proteins and neuropeptide Y in vivo. Neuroreport 2003;14:2183-2187.
63. Starr PA, Rau GM, Davis V, et al. Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's Disease and normal macaque. J Neurophysiol 2005;93:3165-3176.
64. Tang JKH, Moro E, Mahant N, Hutchison WD, Lang AE, Lozano AM, Dostrovsky JO. Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's disease. J Neurophysiol 2007;98:720-729.
65. Nambu A, Chiken S, Shashidharan P, et al. Reduced pallidal output causes dystonia. Front Syst Neurosci 2011;5:89.
66. Kalanithi PSA, Zheng W, Kataoka Y, et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 2005;102:13307-13312.
67. Kataoka Y, Kalanithi PS, Grantz H, Schwartz ML, Saper C, Leckman JF, Vaccarino FM. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette Syndrome. J Comp Neurol 2010;518:277-291.
68. Drago J, Padungchaichot P, Wong JY, et al. Targeted expression of a toxin gene to D1 dopamine receptor neurons by cre-mediated site-specific recombination. J Neurosci 1998;18:9845-9857.
69. Gantois I, Fang K, Jiang L, et al. Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior. Proc Natl Acad Sci U S A. 2007;104:4182-4187.
70. Wong JY, Padungchaichot P, Massalas JS, Drago Late direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons. Neuroscience 2000;95:1035-1041.
71. Tomiyama K, Kim HA, Kinsella A, et al. Phenotypic disruption to orofacial movement topography in conditional mutants with generalized CamKIIa/Cre D1Tox versus striatal-specific DARPP-32/Cre D1Tox ablation of D1 dopamine receptor-expressing cells. Synapse 2011;65:835-842.
72. Ha AD, Beck CA, Jankovic J. Intermediate CAG repeats in Huntington's disease: analysis of COHORT. Tremor Other Hyperkinet Mov (N Y) 2012;2:tre-02-64-287-4.
73. Seay M, Giuliano J, Handley O; Enroll HD Steering Committee. Enroll-HD: a prospective observational study in a global Huntington's disease cohort. J Neurol Neurosurg Psychiatry 2012;83:A46-A47.
74. Waldvogel HJ, Faull RL, Williams MN, Dragunow M. Differential sensitivity of calbindin and PARV immunoreactive cells in the striatum to excitotoxins. Brain Res 1991;546:329-335.